
ImpriMed
Palo Alto, CA, United States imprimedicine.com
From their website, Nov 2026
Work here? Claim this listing
About
ImpriMed provides AI-driven precision medicine services for veterinary oncology, human blood-cancer oncology, and pharmaceutical CRO clients. It works with veterinarians, physicians, oncologists, and pharmaceutical companies from Palo Alto, California.
Services
Veterinary precision medicine
Provides personalized drug response predictions for canine and feline blood cancers.
Human precision medicine
Predicts patient-specific drug responses using precision analytics for human oncology.
Ex vivo CRO services for pharma
Uses live-cell-based analytics to support oncology drug development programs.
Combination optimization
Ranks synergistic regimens in primary patient cells.
Drug-resistance profiling
Evaluates activity where standard of care fails.
Biomarker validation
Tests candidate markers for use in enrichment rules.
Translational immunotherapy
Measures antigen, engagement, and killing in patient cells.
Flow cytometry panels
Offers add-on flow cytometry panel analysis.
Sequencing and transcriptomics
Offers sequencing and transcriptomics as add-on modules.
Cryopreservation and biobanking
Provides cryopreservation and biobanking as an add-on module.
Personalized prediction profile
Provides veterinary response prediction reports.
Flow cytometry and CHOP predictions
Provides veterinary flow cytometry and CHOP-related prediction services.
Immunoprofile flow cytometry
Provides veterinary immunoprofiling by flow cytometry.
PARR
Offers PARR testing for veterinary services.
Multidrug sensitivity genotyping (MDR1)
Offers MDR1 genotyping for veterinary services.
Cytology
Offers cytology for veterinary services.
- Turnaround
- Within 1-2 business days
- What to send
- Single primary patient sample · Primary patient cells
Capabilities
- Assays and studies
- Flow cytometry · NGS · Bispecifics · ADCs · Peptides · Oligonucleotides · Small molecules · Ex vivo drug sensitivity · Dose-response · AUC · E max · Drug combination synergy
8 more
Synergy scoring · Antagonism scoring · Multiparameter flow cytometry · Drug effect · Antigen density · Target engagement · Malignant vs. normal selectivity · ML-integrated analysis - Scale and capacity
- Single primary patient sample · 20+ drug standard panel
- Therapeutic areas
- Oncology · Veterinary oncology · Blood cancers · Acute myeloid leukemia · Acute lymphoblastic leukemia · Non-Hodgkin lymphoma · Multiple myeloma · Myelodysplastic syndromes · Comparative oncology
Instruments and platforms
- Flow cytometry
Modalities and species
- Modalities
- Small molecule · Bispecific · ADC · Peptide · Oligonucleotide
- Species and models
- Canine · Feline · Primary patient cells · Primary human cells · Blood-cancer patient cells · Blast compartments · Stem-cell compartments · Differentiated compartments · Immune compartments
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO/IEC 17025Self-reported
CLIASelf-reported
Company
- Type
- CRO
- Quality
- FDA Modernization Act 2.0 (2022) (human-derived, cell-based functional data)
Locations
- Based in
- Palo Alto, CA, United States
- Sites
- Palo Alto, USA
Public records
- Biocom California CRO directory
- Biomarker Discovery & Validation, Ex vivo drug sensitivity testing, Patient Stratification, Translational Oncology CRO source
Similar labs
Work here? Claim this listing